申请人:Hoffmann-La Roche Inc.
公开号:US04605674A1
公开(公告)日:1986-08-12
Antivirally active compounds of the formula ##STR1## wherein R.sup.1 represents hydroxy, acyloxy derived from an aliphatic acid having 2-18 carbon atoms or a heterocyclic carboxylic acid containing nitrogen atom(s), lower alkoxycarbonyloxy, aminoacyloxy or carboxyalkanoyloxy; R.sup.2 represents lower alkoxy; R.sup.3 represents hydrogen or lower alkoxy; and R.sup.4 represents phenyl which may be substituted by one or more substituents selected from the group consisting of lower alkyl, lower alkoxy, benzyloxy, allyloxy, alkylthio, dialkylamino, amino, cyano, hydroxy, halo and alkylenedioxy; or pyridyl, furyl, thienyl or pyrrolyl which may be substituted by lower alkyl, pharmaceutical compositions containing them and a process for the preparation of those compounds of formula I which are novel.
式##STR1##中的抗病毒活性化合物,其中R.sup.1代表羟基,来自具有2-18个碳原子的脂肪酸或含氮原子的杂环羧酸的酰氧基,较低的烷氧羰氧基,氨基酰氧基或羧基烷酰氧基;R.sup.2代表较低的烷氧基;R.sup.3代表氢或较低的烷氧基;R.sup.4代表苯基,可以被来自由下列成员的一个或多个取代基所取代:较低的烷基,较低的烷氧基,苄氧基,烯丙氧基,烷基硫醚,二烷基氨基,氨基,氰基,羟基,卤素和烷基二氧基;或吡啶基,呋喃基,噻吩基或吡咯基,可以被较低的烷基取代,其中包含它们的药物组成物以及一种制备那些新颖的式I化合物的过程。